Nivolumab

SUSPENDED · PHASE2 · Microsatellite-stable Colorectal Cancer, Standard of Care, Nivolumab, Bevacizumab

PI Request

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.